Trial Profile
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs BAY 949392 (Primary)
- Indications Heart disorders; Inflammation; Myocardial disorders; Sarcoidosis
- Focus Diagnostic use
- 15 Mar 2023 Number of arms changed from 2 to 1. Arm 18F-FSPG PET/CT removed from study protocol. Allocation changed to N/A. Interventional study model changed from parallel to single group assignment.
- 15 Mar 2023 Status changed from recruiting to discontinued due to loss of funding.
- 31 Mar 2022 Planned End Date changed from 1 Apr 2023 to 1 Apr 2024.